Qilian International Holding Group Ltd./$BGM

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Qilian International Holding Group Ltd.

BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.

Ticker

$BGM
Sector
Health Care
Primary listing
NASDAQ

Industry

Pharmaceuticals
Headquarters
Chengdu, China

Employees

323
Website
www.bgmgroupltd.com

BGM Metrics

BasicAdvanced
$1.8B
-
-$0.20
-
-

Bulls say / Bears say

BGM Group Ltd. has strategically expanded its AI application portfolio through the acquisition of HM Management Company Limited, aiming to integrate with existing AI insurance and mobility businesses, potentially enhancing its competitive position in the broader AI industry. (stocktitan.net)
The company's adoption of a new corporate structure, including a revised Memorandum and Articles of Association, provides expanded corporate capabilities and share structuring options, offering strategic flexibility for operations and capital management. (nasdaq.com)
BGM Group Ltd. has undergone a comprehensive reorganization plan involving multiple entities, which could signal a new phase of growth and restructuring, potentially impacting market performance positively. (nasdaq.com)
The issuance of 16.7 million new shares for the acquisition of HM Management Company Limited increases the total share count by 8.31%, potentially leading to shareholder dilution and pressuring per-share metrics. (stocktitan.net)
The company's dual-class share structure results in the newly issued Class A shares carrying only 0.76% of total voting power, highlighting a concentration of governance and potential concerns about shareholder influence. (stocktitan.net)
The recent 1-for-5 reverse stock split, effective June 21, 2024, may not lead to a sustained increase in share price, as market price post-reverse split is uncertain and may not align with the consolidation ratio. (bgm.ltd)
Data summarised monthly by Lightyear AI. Last updated on 7 Jul 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $BGM

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs